Startseite>>Signaling Pathways>> Others>>(R)-Oxiracetam

(R)-Oxiracetam

Katalog-Nr.GC34991

(R)-Oxiracetam ist das (R)-Enantiomer des Nootropikums Oxiracetam. Oxiracetam (ISF 2522) ist ein Nootropikum aus der Familie der Racetame und ein Stimulans.

Products are for research use only. Not for human use. We do not sell to patients.

(R)-Oxiracetam Chemische Struktur

Cas No.: 68252-28-8

Größe Preis Lagerbestand Menge
5mg
130,00 $
Auf Lager
10mM (in 1mL Water)
142,00 $
Auf Lager
50mg
732,00 $
Auf Lager
100mg
1.294,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam. Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.IC50 value:Target: nootropic drugOxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.[1][2] Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time.[medical citation needed] However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.

[1]. Malykh AG, et al. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs. 2010 Feb 12;70(3):287-312. [2]. Valzelli L, et al. Difference in learning and retention by Albino Swiss mice. Part III. Effect of some brain stimulants. Methods Find Exp Clin Pharmacol. 1986 Jun;8(6):337-41.

Bewertungen

Review for (R)-Oxiracetam

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-Oxiracetam

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.